Clinical Trial Update: Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled trial evaluating AIN457 for efficacy in moderate to severe ankylosing spondylitis has completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• AIN457

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED | Results posted: 2015-09-18